Thank you for submitting your manuscript for consideration by The EMBO Journal. Two referees have now evaluated it, and their comments are shown below. As you will see, while referee 2 is more critical, referee 1 is clearly more supportive. After further consultation with referee 1 and internal discussions, we have now come to the conclusion that we would be happy to consider a revised version of the manuscript that addresses the issues put forward by the referees in an adequate manner. It will be important to strengthen the causal link between the increase in membrane disorder induced by short-chain ceramide in vitro and Golgi-derived trafficking in cells with additional experimental approaches along the lines suggested by and to the full satisfaction of referee 1.
I should add that it is EMBO Journal policy to allow only a single round of revision and that acceptance or rejection of your manuscript will therefore depend on the completeness of your responses in this revised version as well as on the final assessment by the referees.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely Editor
The EMBO Journal
REFEREE REPORTS Referee #1
This manuscript describes the finding that challenge of mammalian cells with short chain ceramide results in an enantiomer-specific inhibition of multiple pathways of membrane trafficking from the Golgi complex. A series of sophisticated experiments demonstrate that inhibitory conditions correlate with metabolism of the incorporated ceramide and with reduced order in Golgi membranes. The short-chain ceramide-effect reflects specific inhibition of carrier vesicle biogenesis in Golgi membranes rather than vesicle fusion to such membranes. This manuscript suggests that L0 domains in Golgi membranes are required for carrier vesicle biogenesis. While ceramide involvements in Golgi transport was previously described in two different contexts by the Pagano and Simons groups, this manuscript provides new and important mechanistic insights into the shortchain ceramide effect. The work will be of interest to a broad scientific audience.
The experiments described are well-done and well-designed, and the parallel use of short-chain Dand L-ceramides nicely controls the experiments from the biophysical point of view. The vesicle biogenesis vs vesicle fusion studies are clever, informative and congruent with the other results (particularly the lipidomics and EM data). This work requires additional experimentation in several key areas, however, and those weaknesses need to be addressed. The primary issues are as follows:
First, the authors appear comfortable in interpreting the correlation between the short-chain Dceramide effects on membrane trafficking and membrane disorder as causative effects. The GUV experiments, while well-executed, do not elevate the data above a correlation. While the interpretation is certainly plausible, the experiments should be backed up by imposing membrane disorder on Golgi membranes in other ways. One example would be to interfere with sterol synthesis or homeostasis using either inhibitors, or by feeding cells sterols that do not cooperate with SM to generate L0-domains. Such challenges should recapitulate the short-chain D-ceramide effects.
Second, the lipidomic analyses demonstrate that the bulk levels of C6-SM are about 15 mol%. While this concentration is likely higher in Golgi membranes, at what level of substitution of C6-SM for authentic SM (i.e. c6-SM/SM ratio) is L0-domain formation affected in the GUV assay?
Third, the trafficking experiments with VSV-G and GPI-anchored proteins are not quantitative as these are based on immunofluorescence assays. The authors should measure plasma membrane and internal pools using pulse-chase strategies coupled to protease shaving or external labeling approaches. Those results would strengthen the trafficking data given the HRP reporter is a soluble cargo while VSV-G and GPI-anchored proteins are integral membrane proteins. These may behave differently.
Fourth, a direct relationship between short-chain ceramide-mediated increases in membrane disorder and trafficking is expected to exhibit particular properties in time-course experiments. In the washout studies, does restoration of membrane order coincide with, or precede, recovery of transport? The authors' interpretation demands this be so, and the experiment needs to be done.
Fifth, the fact that CERT-deficient cells are viable (and CERT null mutants produce fully-developed flies) suggests that the Golgi function quite normally in those contexts. While cultured cells acquire sphingolipids from the serum, one should be able to generate conditions where this salvage is minimized so that Golgi transport competence can be measured in an SM-deficient Golgi. One would expect CERT-deficient cells should mimic D-ceramide-challenged cells in terms of trafficking and that SM-feeding should remediate the defect.
Referee #2
The Golgi apparatus is a central platform for membrane traffic, where vesicular intermediates fuse and bud, and also a compartment where major changes in lipid composition occur: enrichment in negatively charged lipids and cholesterol, increase in bilayer asymmetry; synthesis of complex sphingo lipids from ceramides. In this study, Duran and co authors compare two enantiomers of ceramides for their effects on the Golgi transport and Golgi structure. From their results, they conclude that liquid-ordered domains form at the Golgi and are required for vesicle biogenesis.
The quality of the experiments is not even: those aimed at assessing the effect of L and D short chain ceramides on cargo traffic, tubules formation, IQ-mediated vesicularisation are very convincing and the effects are clear cut. However, I have some concerns about the novelty, interpretation or quality of other experiments as detailed below. Overall I think that there is a gap between the cellular observations and the physical model used to interpret the results. Figure 2 . This lipid analysis demonstrates that HeLa cells are able to metabolize D C6-ceramide but not the L enantiomer into more complex lipids (sphingomyeline and glucosylceramide). However, there is no parallel increase in the total level of diacyl glycerol ( figure 2B, lower panel) . Therefore, the interpretation of the cell pictures shown in Figure 1 is questionable (first result section), unless the authors can show, after cell fractionation, that there is a significant increase in DAG at the Golgi due to incubation with D C6-ceramide. Also the Golgi should become very rich in short chain sphingolipids.
#3. Model membranes, GUVs and domain formation. It is claimed in the text (p6) "However it is not known whether short chain SM can form or perturb liquid-ordered domain". In fact, at least two studies on this topic have been published and their conclusions were very similar: "short-chain Cer do not form a separate phase but alter the physical properties of the liquid-ordered domains, decreasing their stability and viscosity and perturbing the lipid packing » (Chiantia S, Kahya N, Schwille P (2007) Langmuir. 23:7659-65).
« Our present findings demonstrate the need for an additional caution in interpreting the results of studies of intracellular trafficking of short-chain fluorescent sphingolipids, namely that the abilities of these species to partition into sphingolipid-rich "raft" domains may be quantitatively and even qualitatively different from those of long-chain cellular sphingolipids. « Wang TY, Silvius JR (2000) Biophys J. 79:1478-89.
Despite the fact that the approaches used in these two papers are different, I am afraid that they seriously diminish the novelty of the present study. It is also important to note that not only the products of short chain ceramides, but also short chain ceramides themselves should diminish the propensity of a given membrane to form liquid ordered phases. Again one would need to know where the various lipids are distributed within the cell; notably the substrates, because short chains L and D ceramides should also cause a reduction in liquid-ordered domain formation. Figure 3C ) indicates the results of polarization measurements in cell. This result is very important but poorly explained and developed. Technically, monitoring the lipid organization of an organelle in a cellular context is challenging. Please give as much details as possible for these measurements. Show results from different cells; use other organelles as controls; indicate the range of absolute values of GP that is expected depending on the state of the membrane. For a bulk measurement of a membrane fraction in a fluorimeter, a polarization value should be sufficient. Here however, it would be more convincing to show the actual GP images of cells. Figure 5E are beautiful. In the absence of IQ, do L-Cer and D-Cer induce differences in the morphology of the Golgi apparatus? I suppose that IQ was used to exacerbate the formation of vesicular structures. However, one may also anticipate some changes in the absence of this drug. Along the same line, is it possible to distinguish the cis and trans sides of the Golgi? Do treatments with D ceramides affect the morphology and dynamics of the trans Golgi vs cis Golgi?
#4. One graph (

#5. The EM pictures shown in
1st Revision -authors' response 10 October 2012
Referee #1 We report that there is a transport inhibition from the Golgi membranes in D-ceramide-C6 treated cells, and that this treatment causes a reduction in Golgi membrane order as shown by laurdan GP measurements in HeLa Golgi membranes. In addition, this change in membrane order is correlated with a loss of ordered domains in GUVs where SM-C16 is gradually being replaced by SM-C6. The suggestion of the reviewer to reduce the Golgi membrane lipid order by other means and test for transport defects is very interesting, however, these experiments introduce non-specific effects. First, the key aspect of our procedure is the fact that we are able to specifically reduce the membrane order in the Golgi membranes, as D-ceramide-C6 is metabolized in the Golgi membranes. Instead of relying on drugs that can potentially affect several pathways, we plan to use more specific genetic means to control cholesterol levels in the Golgi membranes. However, our current paper is really packed with data and the new studies are beyond the scope of this paper. However, to strengthen our claim that transport inhibition upon D-ceramide-C6 treatment was indeed due to the local increase of short-chain (non-raft-forming) SM in expense of endogenous long-chain (raft-forming) SM, we knocked down both SMS1 and SMS2: the enzymes that catalyze ceramide conversion to SM, and measured HRP secretion in the presence of L-or D-ceramide-C6. Our results clearly show that the knockdown of these enzymes alleviates the D-ceramide-C6 mediated block in HRP secretion ( Figure 3L and Figure S4A -B). We also provide evidence that formation of short-chain SM, but not short-chain glucosylceramide, affects transport as treatment with the glucosylceramide synthase inhibitor (PDMP) reduced the levels of newly metabolized glucosylceramide, but did not rescue D-ceramide-C6 induced HRP secretion block ( Figure S4C-D) .
This manuscript describes the finding that challenge of mammalian cells with short chain ceramide results in an enantiomer-specific inhibition of multiple pathways of membrane trafficking from the Golgi complex. A series of sophisticated experiments demonstrate that inhibitory conditions correlate with metabolism of the incorporated ceramide and with reduced order in Golgi membranes. The short-chain ceramide-effect reflects specific inhibition of carrier vesicle biogenesis in Golgi membranes rather than vesicle fusion to such membranes. This manuscript suggests that L0 domains in Golgi membranes are required for carrier vesicle biogenesis. While ceramide involvements in Golgi transport was previously described in two different contexts by the Pagano and Simons groups, this manuscript provides new and important mechanistic insights into the shortchain ceramide effect. The work will be of interest to a broad scientific audience.
The experiments described are well-done and well-designed, and the parallel use of short-chain Dand L-ceramides nicely controls the experiments from the biophysical point of view. The vesicle biogenesis vs vesicle fusion studies are clever, informative and congruent with the other results (particularly the lipidomics and EM data). This work requires additional experimentation in
2) Second, the lipidomic analyses demonstrate that the bulk levels of C6-SM are about 15 mol%. While this concentration is likely higher in Golgi membranes, at what level of substitution of C6-SM for authentic SM (i.e. c6-SM/SM ratio) is L0-domain formation affected in the GUV assay?
In order to address this point, we did two complementary experiments. First, we analyzed the whole lipidome of isolated Golgi membranes (about six-fold enrichment judged by the TGN46 and SPCA1 Golgi markers ( Figure S2) ) from control or D-ceramide-C6-treated HeLa cells. The results of this experiment show that the C6-SM/total SM ratio increased from the aforementioned 10-15% in whole cells to over 20% in our enriched fraction ( Figure 2C-D) . This more accurately reflects the levels of C6-SM in the Golgi membranes. We also performed experiments with GUVs at various ratios of C6-and C16-SM. These experiments show that when 10% of total SM in the GUV mixture is C6-SM, phase separation still occurs. However, liquid-ordered domains become smaller and less ubiquitous when the fraction of short-chain SM over total SM is up to 30% ( Figure S6C ). This data is in agreement with mass-spectrometry data on isolated Golgi membranes mentioned above. We now present data on the VSV-G-GFP transport to the plasma membrane by a cell surface biotinylation assay. The data shows clearly a quantitative defect in traffic of VSV-G to the cell surface in cells treated with D-ceramide-C6 compared with control cells ( Figure 3I ). Additionally, we measured total bulk secretion by a metabolic labeling pulse-chase experiment. This data clearly and quantitatively shows that there is a general defect in protein secretion in HeLa cells treated with D-ceramide-C6 compared to L-ceramide-C6-treated cells ( Figure 3A) . Since the GPI-GFP data is only based on immunofluorescence, we decided to move it to the supplementary figures ( Figure  S3A ). We have not done this experiment. This is not because of a lack of interest but we believe that given all the other new data, there is no need to include for this piece of information. The referee is completely right about the viability of CERT-deficient flies, but to conclude that the Golgi functions are normal in CERT-deficient flies in not entirely correct. Those flies have a reduced lifespan and exhibit metabolic dysfunctions. Moreover, those conditions are not directly comparable to the treatment with D-ceramide-C6. In CERT-null flies, the production of SM is reduced but not completely abrogated. This is probably because ceramide can reach the TGN by vesicular transport albeit slowly, and metabolized by SMS to produce SM. Therefore, liquid-ordered domains might still be generated and we would like to test this in the future. However, our paper is packed with data in the current form, performing the experiments suggested by the reviewer would add a whole new dimension to the paper but currently beyond our scope.
3) Third, the trafficking experiments with VSV-G and GPI
4) Fourth
5) Fifth
Referee #2
The 
#1. Figure 1. According to the figure legend and annotations, panel C compares the Golgi recruitment of PKD2 in untreated cells and in cells treated with D-ceramide. However, it is claimed in the text that L and D enantiomers are compared. This comparison makes more sense. Please show data comparing the 3 conditions: no addition, L ceramide, D ceramide. Same comment applies for panel B
We apologize for the discrepancy between the figure and the text. In this new version of Figure 1 we show, as suggested by this reviewer, the comparison of L-and D-ceramide-C6 treated cells (for both GST-C1a-PKD1 domain and GST-PKD2-WT localization).
#2. Figure 2. This lipid analysis demonstrates that HeLa cells are able to metabolize D C6-ceramide but not the L enantiomer into more complex lipids (sphingomyeline and glucosylceramide). However, there is no parallel increase in the total level of diacyl glycerol (figure 2B, lower panel). Therefore, the interpretation of the cell pictures shown in Figure 1 is questionable (first result section), unless the authors can show, after cell fractionation, that there is a significant increase in DAG at the Golgi due to incubation with D C6-ceramide. Also the Golgi should become very rich in short chain sphingolipids.
In this revision, we include data from the lipidome of isolated Golgi membranes from control or cells treated with D-ceramide-C6. We show that the isolated fraction is 6-fold enriched in TGN specific markers ( Figure S2 ). The analysis of the lipidome of these membrane fractions ( Figure 2C-D) show that, as anticipated by this referee, the Golgi membranes become highly enriched in shortchain SM (from 10-15% of total SM in whole cells to more than 20% in our enriched Golgi membranes). Also, there is a 30% increase in the DAG levels. It is important to note that DAG production under D-ceramide-C6 treatment occurs only at the Golgi membranes and, therefore, it is not clearly detected in the lipidome analysis of the whole cell but clearly evident in isolated Golgi membranes.
In addition, it is important to note that DAG is, usually, rapidly metabolized. Therefore the 30% increase detected in the lipidomic analysis from Golgi membranes could be translated to a even higher increase in vivo, as some DAG could have been metabolized during the isolation. Alternatively, the presence of a DAG-binding overexpressed protein (like the C1a domain of PKD, or the full length PKD2 as shown in Figure 1 ) might affect its conversion in the analyzed cells. These were indeed the reasons that prompted us to analyze the lipid levels in whole cells, in order to strengthen the data obtained using the DAG sensors. (Chiantia S, Kahya N, Schwille P (2007) It is important to note that in one of the studies (Chiantia et al.) the authors tested the ability of C6-ceramide in forming liquid-ordered domains, but not its metabolite C6-SM. In the other study (Wang and Silvius), fluorescently labeled C6-NBD-SM and C5-Bodipy-SM were used. It is also is not clear whether the physical properties of NBD-or Bodipy-labeled lipids are analogous to their unlabeled counterparts. Moreover, the published papers do not reveal the effect of C6-ceramide and the labeled lipids on membrane transport and Golgi membrane organization. Overall, we believe our findings are novel with respect to the analysis of lipid metabolites generated treating cells with Dceramide-C6 and then revealing their effects on the Golgi membranes and cargo export.
#3. Model membranes, GUVs and domain formation. It is claimed in the text (p6) "However it is not known whether short chain SM can form or perturb liquid-ordered domain". In fact, at least two studies on this topic have been published and their conclusions were very similar: "short-chain Cer do not form a separate phase but alter the physical properties of the liquidordered domains, decreasing their stability and viscosity and perturbing the lipid packing »
#4. One graph (Figure 3C) indicates the results of polarization measurements in cell. This result is very important but poorly explained and developed. Technically, monitoring the lipid organization of an organelle in a cellular context is challenging. Please give as much details as possible for these measurements. Show results from different cells; use other organelles as controls; indicate the range of absolute values of GP that is expected depending on the state of the membrane. For a bulk measurement of a membrane fraction in a fluorimeter, a polarization value should be sufficient. Here however, it would be more convincing to show the actual GP images of cells.
As requested by this referee, we have now added actual images of cells with the GP values, together with the masked images of the Mannosidase II-RFP positive areas. However, given all the other new data presented and for the sake of space, we have not performed the other experiments suggested by the reviewer. Figure 5E are beautiful.
#5. The EM pictures shown in
In the absence of IQ, do L-Cer and D-Cer induce differences in the morphology of the Golgi apparatus? I suppose that IQ was used to exacerbate the formation of vesicular structures. However, one may also anticipate some changes in the absence of this drug. Along the same line, is it possible to distinguish the cis and trans sides of the Golgi? Do treatments with D ceramides affect the morphology and dynamics of the trans Golgi vs cis Golgi?
In order to address this issue, we observed by electron microscopy cells treated with ethanol (vehicle), L-or D-ceramide-C6 for only 30 minutes, and also in cells which were treated for 30 min with these chemicals, and then washed and cultured in complete medium for an additional 90 min. In the first case, the secretion defect just started, as seen in our HRP secretion assay ( Figure 3C ), meaning that any morphological changes that might appear as a consequence of the fission but not fusion defect would still not be visible. In the second case, fission is blocked for 90 minutes without affecting the fusion of incoming carriers. While the former membranes are apparently normal ( Figure S5A ), the latter show an extreme morphology, where the initially flat Golgi cisternae are curled ( Figure S5B ). This, we suggest, is due to an imbalance between membrane export vs. membrane import. This unbalanced membrane flux implies a much larger relative increase in the membrane area compared to the enclosed volume or, in other words, a decrease in the volume-toarea ratio of the Golgi cisternae. Such changes have been studied biophysically to induce the transition of flat oblate cisternae-like membranes into curled stomatocyte-like objects (Berndl et al, 1990; Seifert et al, 1991) . Thanks for submitting your revised manuscript to the EMBO Journal. Your study has now been rereviewed by referees #1 and 2. Both referees appreciate the introduced changes. Referee #2 is happy with the revised version, but would like to see some issues better discussed. Referee #1 requests that a few minor issues are resolved before final acceptance here. Regarding the comments of referee #1: I recognize that points (ii) and (iii) were not directly brought up during the initial round of review and I will therefore not insist on the inclusion of such data. Nevertheless if you have data on hand to address these comments it would be nice to include them. Regarding point (i): do you have data to address the order of events (protein transport and membrane order) taking place after D6-Cer washout? This is the remaining issue that needs to be resolved. When you submit your revised manuscript please also include a detailed point-by-point.
We also now encourage publication of source data, particularly for electrophoretic gels and blots. Would you be willing to provide a PDF file per figure that contains the original, uncropped and unprocessed scans of all or key gels? The PDF files should be labelled with the appropriate figure/panel number, and should have molecular weight markers; further annotation could be useful but is not essential. The PDF files will be published online with the article as supplementary "Source Data" files. If you have any questions regarding this just contact me.
Best regards Editor
The EMBO Journal REFEREE REPORTS Referee #1
The authors have made a strong response to the critiques of the original submission. In doing so, they have strengthened the MS considerably and the revised MS is also written more clearly. Several issues, mostly minor technically but important nonetheless, remain. These are:
(i) Item 4 --Reviewer 1. The authors really must do this experiment. The comparisons of time course of secretion restoration after D6-Cer washout relative to restoration of membrane order speak directly to the mechanism proposed. Interpretation of the data would change if secretion is restored more quickly than membrane order, or if membrane order is restored more quickly than secretion. That other data were included does not diminish the importance of this point.
(ii) It would be informative to provide EM micrographs of cells treated with D6-Cer. Does Golgi morphology change? One would certainly expect this given the apparently general and dramatic secretion block imposed by D6-Cer challenge. The result is of interest one way or the other and should be documented.
(iii) The authors document a D6-SM-mediated block in Golgi secretory function even though DAG levels are boosted and PKD is efficiently recruited to Golgi membranes. These are pro-secretory factors yet there is a block. What happens to Golgi PI4P? Perhaps Golgi PI 4-kinase activity is sensitive to membrane order. A FAPP1-GFP reporter experiment would address this issue. Again, the result is of interest one way or the other and should be documented. Knowing this result will sharpen interpretation of the data considerably.
Referee # 2
The authors have addressed some of the points raised during the first round of review. Overall I think that the data shown are of high quality, notably for the cell biology approaches. The lipidomics analysis of Golgi fractions is also a noticeable improvement compared to the original manuscript. I still have the same concern as regards to the interpretation of the data throughout the raft hypothesis: in brief, I am not convinced that the defects in membrane budding reactions at the Golgi induced by C6-ceramide is due to the lack of LO domain formation. After all, it could be due to another physical change in the luminal leaflet preventing membrane budding (e.g. related to membrane thickness, membrane bending modulus, mismatch with TM proteins...). However, at this point, I understand that this remains hypothetical and difficult to address experimentally. In my opinion, the new images of Laudran polarization in Figure 5C that I asked for, show that, at best, the observed effects by this approach are very limited: I can hardly see any difference between the upper and lower panels. Perhaps the authors could be more open to other interpretations in the discussion. Notwithstanding, I recommend publication of this interesting study.
2nd Revision 06 November 2012
We thank the reviewers and your kind support. We have addressed all the concerns to the best of our abilities. The first and the third issue of reviewer #1 will require additional procedures that are beyond the scope of this manuscript. The second item requested by this reviewer was in fact an issue raised by reviewer # 2 and was included in our revised manuscript.
Reviewer #2 suggested that we change the text to discuss alternative reasons for sphingomyelin dependent changes in Golgi architecture and traffic, which are now addressed in the discussion.
Referee #1
We (ii) It would be informative to provide EM micrographs of cells treated with D6-Cer. Does Golgi morphology change? One would certainly expect this given the apparently general and dramatic secretion block imposed by D6-Cer challenge. The result is of interest one way or the other and should be documented. figure S5) . The figure shows that after 30 min D-ceramide-C6 treatment there is no change in the organization of the Golgi membranes. However, 90 min after D-ceramide-C6 washout, the Golgi membranes appear highly curled, which we suggest could be due to an imbalance in the membrane import vs. export.
This EM data was included in the revised manuscript (Supplemental
We plan to address these important issues in the future by using a more quantitative in vitro assay. Referee # 2
We have changed the title and the abstract, and we also included a statement in the discussion discussing that effects on traffic could also be due to other biophysical changes created by the perturbed levels of sphingomyelin.
Acceptance letter 06 November 2012
Thank you for submitting your revised manuscript to the EMBO Journal. I appreciate the introduced changes and I am pleased to proceed with the acceptance of the paper for publication in The EMBO Journal.
With best regards Editor
